Format

Send to

Choose Destination
Addict Biol. 2018 Jan;23(1):485-492. doi: 10.1111/adb.12496. Epub 2017 Feb 23.

Polygenic risk scores for schizophrenia and bipolar disorder associate with addiction.

Author information

1
deCODE genetics/Amgen, Iceland.
2
MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
3
MRC Integrative Epidemiology Unit, Oakfield House, Oakfield Grove, University of Bristol, BS8 2EG, UK.
4
Department of Psychiatry, Landspitalinn University Hospital, Iceland.
5
Humus, Reykjavik, Iceland.
6
SAA-National Center of Addiction Medicine, Iceland.
7
Faculty of Psychology, University of Iceland, Iceland.
8
Department of Engineering and Natural Sciences, University of Iceland, Iceland.
9
Faculty of Medicine, University of Iceland, Iceland.

Abstract

We use polygenic risk scores (PRSs) for schizophrenia (SCZ) and bipolar disorder (BPD) to predict smoking, and addiction to nicotine, alcohol or drugs in individuals not diagnosed with psychotic disorders. Using PRSs for 144 609 subjects, including 10 036 individuals admitted for in-patient addiction treatment and 35 754 smokers, we find that diagnoses of various substance use disorders and smoking associate strongly with PRSs for SCZ (P = 5.3 × 10-50 -1.4 × 10-6 ) and BPD (P = 1.7 × 10-9 -1.9 × 10-3 ), showing shared genetic etiology between psychosis and addiction. Using standardized scores for SCZ and BPD scaled to a unit increase doubling the risk of the corresponding disorder, the odds ratios for alcohol and substance use disorders range from 1.19 to 1.31 for the SCZ-PRS, and from 1.07 to 1.29 for the BPD-PRS. Furthermore, we show that as regular smoking becomes more stigmatized and less prevalent, these biological risk factors gain importance as determinants of the behavior.

KEYWORDS:

polygenic scores; psychotic disorders; substance abuse

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center